Dr. Basu is Head of the Early Detection, Prevention and Infections Branch at the International Agency for Research on Cancer (WHO), France. Dr. Basu is well known for his research that has informed several guidelines and recommendations from the WHO and other international organizations. He has led several projects that led to technology development, such as thermal ablation for cervical precancer, HPV detection technologies, AI-supported detection of cervical neoplasia etc. Dr. Basu has significantly contributed to build capacity in delivering quality assured cancer early detection services in several countries across the globe through his CanScreen5 project.

Chen Gao, senior project manager at Tencent's Sustainable Social Value Division, graduated from ENSPM in France and has extensive experience in public health and population medicine across Europe, the US, and Asia. He leads social value innovation projects in maternal and child health, including the "Pilot Project to Prevent and Control Two Cancers for Women" with partners like Peking Union Medical College and the Chinese CDC. The project aims to invest tens of millions of USD over three years to explore innovative models and technologies for preventing and controlling cervical and breast cancer in low-resource areas in China.

Veerle Schevenhoven is a PhD student at the Public Health department of Erasmus MC in Rotterdam. Her research is focused on the evaluation and optimization of the cervical cancer screening program in the Netherlands.

Dorota is the Medical Director of the National Cancer Screening Register (NCSR). She is a public health physician and epidemiologist who completed her medical training at Monash University and has a Doctorate in Epidemiology from the Harvard School of Public Health. Professor Gertig was previously the Medical Director of the Victorian Cervical Cytology Registry and the inaugural Medical Director of NHVPR. Dorota is a respected leader in cancer screening and a member of several key national and state committees on cervical screening. Professor Gertig has an international profile in cancer research, including the epidemiology of cervical, breast and ovarian cancers.

Dr. Jie-Bin Lew is a Senior Research Fellow in the Gastrointestinal Cancers and Policy Evaluation Stream at the Daffodil Centre. Her current research focuses on optimising colorectal cancer screening in Australia and other countries. Her work involves providing evidence on the health benefits, potential harms, and cost-effectiveness of various approaches to identify the ‘best buy’ screening strategy for preventing colorectal cancer population with different risk profile, informing the planning for cancer prevention and control.

Kemal Gogebakan has been a Research Associate at the Fred Hutchinson Cancer Center's Etzioni Lab since June 2023. He earned his PhD in Economics from Turkey. His research focuses on modeling the benefits and harms of cancer screening in trials and population-based programs. He also develops models to evaluate the long-term outcomes of novel diagnostics, with a particular emphasis on precision oncology.

Dr Marlow had worked in cancer screening research for 20 years. Her current research aims to explore the implications of multi-cancer early detection (MCED) screening, including attitudes and acceptability of this approach to screening and psychological impact of results and diagnostic follow-up. She continues to collaborate on cervical screening projects which explore barriers to participation, the acceptability of self-sampling and attitudes towards a choice of self- vs. clinician sampling.